Abstract

Cognitive aging creates major individual and societal burden, motivating search for treatment and preventive care strategies. Behavioural interventions can improve cognitive performance in older age, but effects are small. Basic research has implicated dopaminergic signalling in plasticity. We investigated whether supplementation with the dopamine-precursor L-dopa improves effects of cognitive training on performance. Sixty-three participants for this randomised, parallel-group, double-blind, placebo-controlled trial were recruited via newspaper advertisements. Inclusion criteria were: age of 65–75 years, Mini-Mental State Examination score >25, absence of serious medical conditions. Eligible subjects were randomly allocated to either receive 100/25 mg L-dopa/benserazide (n = 32) or placebo (n = 31) prior to each of twenty cognitive training sessions administered during a four-week period. Participants and staff were blinded to group assignment. Primary outcomes were latent variables of spatial and verbal fluid intelligence. Compared to the placebo group, subjects receiving L-dopa improved less in spatial intelligence (−0.267 SDs; 95%CI [−0.498, −0.036]; p = 0.024). Change in verbal intelligence did not significantly differ between the groups (−0.081 SDs, 95%CI [−0.242, 0.080]; p = 0.323). Subjects receiving L-dopa also progressed slower through the training and the groups displayed differential volumetric changes in the midbrain. No statistically significant differences were found for the secondary cognitive outcomes. Adverse events occurred for 10 (31%) and 7 (23%) participants in the active and control groups, correspondingly. The results speak against early pharmacological interventions in older healthy adults to improve broader cognitive functions by targeting the dopaminergic system and provide no support for learning-enhancing properties of L-dopa supplements in the healthy elderly. The findings warrant closer investigation about the cognitive effects of early dopamine-replacement therapy in neurological disorders. This trial was preregistered at the European Clinical Trial Registry, EudraCT#2016-000891-54 (2016-10-05).

Highlights

  • Cognitive aging creates major individual and societal burden, motivating search for treatment and preventive care strategies

  • We hypothesised that administering L-dopa during cognitive training would increase the effects of cognitive training on general cognitive performance in healthy older adults

  • We designed the present randomised placebo-controlled clinical trial centred on transfer effects of working memory training to fluid intelligence[24,25], which was selected as a primary outcome that may pick up task-independent training effects on working memory ability due to the important role that this ability plays in solving fluid intelligence tasks[26,27,28]

Read more

Summary

Introduction

Cognitive aging creates major individual and societal burden, motivating search for treatment and preventive care strategies. We investigated whether supplementation with the dopamine-precursor L-dopa improves effects of cognitive training on performance. The results speak against early pharmacological interventions in older healthy adults to improve broader cognitive functions by targeting the dopaminergic system and provide no support for learning-enhancing properties of L-dopa supplements in the healthy elderly. Treatment approaches have been unsuccessful, recent studies have demonstrated that combining cognitive training with exercise and a healthy diet can affect cognitive functioning in at-risk older people[2]. Both exercise and dietary nutrients have been put forward as enhancers of neurobiological plasticity[3,4], and may increase effectiveness of cognitive training. The strong involvement of the dopaminergic system in working memory functioning[14,15,29] further motivated this focus

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.